About Ziprasidone Hydrochloride API
Therapeutic Category 中枢神経系 (CNS)
CAS Number
138982-67-9
API Technology
Synthetic
Dose Form
Oral Solid/Capsules, Suspension
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted, Brazil DMF, EUDMF
Mechanism of Action
The mechanism of action of ziprasidone, as with other drugs having efficacy in schizophrenia, is unknown. However, it has been proposed that this drug’s efficacy in schizophrenia is mediated through a combination of dopamine type 2 (D2) and serotonin type 2 (5HT2) antagonism. As with other drugs having efficacy in bipolar disorder, the mechanism of action of ziprasidone in bipolar disorder is unknown.
Indication
GEODON is an atypical antipsychotic. In choosing among treatments, prescribers should be aware of the capacity of GEODON to prolong the QT interval and may consider the use of other drugs first GEODON is indicated as an oral formulation for the:
Treatment of schizophrenia.
- Adults: Efficacy was established in four 4-6 week trials and one maintenance trial in adult patients with schizophrenia. (14.1) Acute treatment as monotherapy of manic or mixed episodes associated with bipolar I disorder.
- Adults: Efficacy was established in two 3-week trials in adult patients with manic or mixed episodes. Maintenance treatment of bipolar I disorder as an adjunct to lithium or valproate.
- Adults: Efficacy was established in one maintenance trial in adult patients. GEODON as an intramuscular injection is indicated for the: Acute treatment of agitation in schizophrenic patients.
- Adults: Efficacy was established in two short-term trials in agitated patients with schizophrenia.
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Related APIs
エスゾピクロン
中枢神経系 (CNS)
アプレミラスト（非晶質およびB型）
中枢神経系 (CNS)
エスリカルバゼピン酢酸塩
中枢神経系 (CNS)
レベチラセタム
中枢神経系 (CNS)
ルマテペロントシル酸塩
中枢神経系 (CNS)
メマンチン塩酸塩
中枢神経系 (CNS)
プレガバリン
中枢神経系 (CNS)
クエチアピンフマル酸塩
中枢神経系 (CNS)
リスペリドン
中枢神経系 (CNS)
リバスチグミン酒石酸塩
中枢神経系 (CNS)
ロピニロール
中枢神経系 (CNS)
スガマデクスナトリウム
中枢神経系 (CNS)
ザノメリン
中枢神経系 (CNS)
ジプラシドン塩酸塩無水物
中枢神経系 (CNS)
チザニジン塩酸塩
中枢神経系 (CNS)
シポニモドヘミフマル酸塩
中枢神経系 (CNS)
オランザピン（I型）
中枢神経系 (CNS)
ドネペジル塩酸塩
中枢神経系 (CNS)
ルラシドン
中枢神経系 (CNS)
アトモキセチン塩酸塩
中枢神経系 (CNS)
ベンザトロピンメシル酸塩
中枢神経系 (CNS)
ジメチルフマル酸塩
中枢神経系 (CNS)
エダラボン
中枢神経系 (CNS)
フルオキセチン
中枢神経系 (CNS)
FAQs
It belongs to the class of Anti-psychotics
-
It is a CNS drug used to treat Schizophrenia
-
The safety dose for Ziprasidone is 20, 40, 60 & 80MG BASE and 10MG BASE/ML
-
We offer Anhydrous form
-
Meet with our product experts in one-on-one virtual sessions at https://api.drreddys.com/meet-api-experts or Write to us at [email protected].
免責事項
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.